Ionotropic glutamate receptors and their implications in cancer and cancer therapeutics
Glutamine, an excitatory neurotransmitter, is necessary for physiological as well as pathological processes. Other than neuronal disorders and/or cancers, glutamate receptors have also been associated with an array of other malignancies. The metabotropic glutamate receptor (mGluR 1–8 [like Groups I,...
Main Authors: | Shree Goyal, Pallab Chakraborty, Balasubramaniam Shankar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Biomedical and Biotechnology Research Journal |
Subjects: | |
Online Access: | http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2021;volume=5;issue=4;spage=349;epage=356;aulast=Goyal |
Similar Items
-
The Lateral Metalation of Isoxazolo[3,4-<i>d</i>]pyridazinones towards Hit-to-Lead Development of Selective Positive Modulators of Metabotropic Glutamate Receptors
by: Christina A. Gates, et al.
Published: (2023-09-01) -
Two Signaling Modes Are Better than One: Flux-Independent Signaling by Ionotropic Glutamate Receptors Is Coming of Age
by: Valentina Brunetti, et al.
Published: (2024-04-01) -
Parkinson’s disease, epilepsy, and amyotrophic lateral sclerosis—emerging role of AMPA and kainate subtypes of ionotropic glutamate receptors
by: Marina N. Vukolova, et al.
Published: (2023-10-01) -
Non-canonical Mechanisms of Presynaptic Kainate Receptors Controlling Glutamate Release
by: José V. Negrete-Díaz, et al.
Published: (2018-04-01) -
Role of Metabotropic Glutamate Receptors in Neurological Disorders
by: Rosalia Crupi, et al.
Published: (2019-02-01)